Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Research programme: liposomal cancer therapies - Xenetic Biosciences

Next Previous
Search
Drug Profile

Research programme: liposomal cancer therapies - Xenetic Biosciences

Alternative Names: Liposomal paclitaxel - Xenetic/Serum Institute of India; LipoTaxen; Paclitaxel liposomal - Xenetic/Serum Institute of India

Latest Information Update: 28 Jul 2018

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Lipoxen Technologies
  • Developer Xenetic Biosciences
  • Class Diterpenes; Paclitaxels; Small molecules; Taxanes
  • Mechanism of Action Angiogenesis inhibitors; Immunosuppressants; Tubulin inhibitors; Tubulin polymerisation promoters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cancer

Highest Development Phases

  • No development reported Cancer

Most Recent Events

  • 28 Jul 2018 No recent reports of development identified for preclinical development in Cancer in United Kingdom (IV, Liposomal)
  • 08 Sep 2011 Lipoxen is now called Xenetic Biosciences
  • 04 Aug 2011 Research programme: liposomal cancer therapies is no longer licensed to Serum Institutes of India

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top